Clinical Trial Update: 68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating 68Ga-DOTA-NOC PET/CT imaging in idiopathic pulmonary fibrosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• 68Ga-DOTA-NOC (Ga-68 DOTA-NOC radiopharmaceutical)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Idiopathic Pulmonary Fibrosis | Phase 4 | Status: TERMINATED